Abstract
AMP-activated protein kinase (AMPK) is an important therapeutic target for the potential treatment of metabolic disorders, cardiovascular disease and cancer. Recently, various classes of compounds that activate AMPK by direct or indirect interactions have been reported. The importance of computer-aided drug design approaches in the search for potent activators of AMPK is now established, including structure-based design, ligand-based design, fragment-based design, as well as structural analysis. This review article highlights the computer-aided drug design approaches utilized to discover of activators targeting AMPK. The principles, advantages or limitation of the different methods are also being discussed together with examples of applications taken from the literatures.
Keywords: AMP-activated protein kinase, activator, structure-based drug design, ligand-based drug design, fragment-based, drug design, structural analysis, fragment-based drug design, QSAR, pharmacophore modellng, molecular docking, virtual screening
Current Computer-Aided Drug Design
Title: Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators
Volume: 7 Issue: 3
Author(s): Zhanli Wang, Jianxin Huo, Lidan Sun, Yongfu Wang, Hongwei Jin, Hui Yu, Liangren Zhang and Lishe Zhou
Affiliation:
Keywords: AMP-activated protein kinase, activator, structure-based drug design, ligand-based drug design, fragment-based, drug design, structural analysis, fragment-based drug design, QSAR, pharmacophore modellng, molecular docking, virtual screening
Abstract: AMP-activated protein kinase (AMPK) is an important therapeutic target for the potential treatment of metabolic disorders, cardiovascular disease and cancer. Recently, various classes of compounds that activate AMPK by direct or indirect interactions have been reported. The importance of computer-aided drug design approaches in the search for potent activators of AMPK is now established, including structure-based design, ligand-based design, fragment-based design, as well as structural analysis. This review article highlights the computer-aided drug design approaches utilized to discover of activators targeting AMPK. The principles, advantages or limitation of the different methods are also being discussed together with examples of applications taken from the literatures.
Export Options
About this article
Cite this article as:
Wang Zhanli, Huo Jianxin, Sun Lidan, Wang Yongfu, Jin Hongwei, Yu Hui, Zhang Liangren and Zhou Lishe, Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators, Current Computer-Aided Drug Design 2011; 7 (3) . https://dx.doi.org/10.2174/157340911796504323
DOI https://dx.doi.org/10.2174/157340911796504323 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natriuretic Peptide Family: New Aspects
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Role of the Endothelium in Premature Atherosclerosis: Molecular Mechanisms
Current Medicinal Chemistry Hedgehog Signaling and Urological Cancers
Current Drug Targets A Review of Premature Frailty in HIV-Infected Persons; Another Manifestation of HIV-Related Accelerated Aging
Current Aging Science At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Current Molecular Medicine Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry Illuminating microRNA Transcription from the Epigenome
Current Genomics HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Current Drug Targets - Cardiovascular & Hematological Disorders Application of Mesenchymal Stem Cells to Age-related Neuronal Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment
Current Pharmaceutical Design How to Recognize Epicardial Origin of Ventricular Tachycardias?
Current Cardiology Reviews Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design An Update on Natural Products with Carbonic Anhydrase Inhibitory Activity
Current Pharmaceutical Design PET Imaging for Gene & Cell Therapy
Current Gene Therapy Current Evidence Regarding Low-carb Diets for The Metabolic Control of Type-2 Diabetes
Current Diabetes Reviews MicroRNAs and the Heart: Small Things Do Matter
Current Topics in Medicinal Chemistry Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Cell-free Nucleic Acids as a Non-Invasive Route for Investigating Atherosclerosis
Current Pharmaceutical Design